Literature DB >> 9165561

Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.

S Ahkee1, S Smith, D Newman, W Ritter, J Burke, J A Ramirez.   

Abstract

We assessed what percentage of hospitalized patients treated with intravenous antibiotics would be candidates for early switch to oral therapy, and evaluated the clinical outcomes of patients after the switch. All hospitalized patients in whom an intravenous antibiotic was prescribed for treatment of an infection were prospectively screened to identify candidates for switch in therapy. Of the 655 patients treated with intravenous antibiotics, 300 (46%) were candidates for a switch, and the change was implemented in 262 (40%). Of the 171 evaluable patients, the switch was associated with clinical cure in 167 (98%) and failure in 4 (2%). In hospitalized patients with infections, the duration of intravenous antibiotic therapy can be minimized with early switch to oral therapy. This practice is associated with good patient outcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165561

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

1.  Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study.

Authors:  Katherine Dunn; Audrey O'Reilly; Bernard Silke; Thomas Rogers; Colm Bergin
Journal:  Int J Clin Pharm       Date:  2011-01-25

Review 2.  Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance.

Authors:  Joseph L Kuti; Blair Capitano; David P Nicolau
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice.

Authors:  J Cooke; M Kubin; T Morris; J Ribas; I Krämer; W Kämmerer; R Fornaini; A C Ballet; P P Sagnier
Journal:  Pharm World Sci       Date:  2002-12

4.  An electronic trigger tool to optimise intravenous to oral antibiotic switch: a controlled, interrupted time series study.

Authors:  Marvin A H Berrevoets; Johannes Hans L W Pot; Anne E Houterman; Anton Ton S M Dofferhoff; Marrigje H Nabuurs-Franssen; Hanneke W H A Fleuren; Bart-Jan Kullberg; Jeroen A Schouten; Tom Sprong
Journal:  Antimicrob Resist Infect Control       Date:  2017-08-15       Impact factor: 4.887

5.  Early Switch From Intravenous to Oral Antibiotics in Skin and Soft Tissue Infections: An Algorithm-Based Prospective Multicenter Pilot Trial.

Authors:  Sandra Dellsperger; Simea Kramer; Michael Stoller; Annika Burger; Elio Geissbühler; Isabel Amsler; Anna Hirsig; Linda Weyer; Ursula Hebeisen; Philipp Aebi; Nicolas Burgherr; Fabienne Brügger; Edouard Chaix; Jérôme Salamoni; Sandra Glauser; Annina Elisabeth Büchi; Charles Béguelin; Gabriel Waldegg; Bernhard Kessler; Martin Egger; Parham Sendi
Journal:  Open Forum Infect Dis       Date:  2022-04-12       Impact factor: 4.423

6.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790

7.  Patterns of antibiotic use and administration in hospitalized patients in Jordan.

Authors:  Anan S Jarab; Tareq L Mukattash; Buthaina Nusairat; Mohammad Shawaqfeh; Rana Abu Farha
Journal:  Saudi Pharm J       Date:  2018-04-18       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.